<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02611011</url>
  </required_header>
  <id_info>
    <org_study_id>4005B</org_study_id>
    <nct_id>NCT02611011</nct_id>
  </id_info>
  <brief_title>Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A Survey</brief_title>
  <official_title>Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A Survey</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gynuity Health Projects</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gynuity Health Projects</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine if women can understand the instructions, carry out the test, and interpret the
      test results. Women will be recruited to complete a test instruction and comprehension
      assessment and a usability assessment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To determine if women can understand the instructions, carry out the test, and interpret the
      test results. Women will be recruited to complete a test instruction and comprehension
      assessment and a usability assessment. Study participants will be a convenience sample of
      women seeking health services. Participants will first be asked to review the instructions
      for the Congo Red Dot Test and complete a short written questionnaire that assesses their
      comprehension of the test instructions. Participants will then be asked to perform the test
      using a test control and to interpret the results obtained by answering a second written
      questionnaire. After the woman performs the test, a healthcare provider will use a matched
      control to perform a second test.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2018</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>CRD Test Comprehension</measure>
    <time_frame>within 5 minutes of reading test instructions</time_frame>
    <description>proportion of women who demonstrated various levels of understanding of the instructions for the CRD Test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>CRD Test Usability</measure>
    <time_frame>within 5 minutes of performing test</time_frame>
    <description>the proportion of women able to correctly use the CRD test</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">198</enrollment>
  <condition>Preeclampsia</condition>
  <arm_group>
    <arm_group_label>Women</arm_group_label>
    <description>Women seeking health services will perform the Congo Red Dot test (GV-005) individually by following the the test instructions</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Congo Red Test (GV-005)</intervention_name>
    <description>The GV-005 is a simple test has been developed to detect unfolded or misfolded proteins in urine.</description>
    <arm_group_label>Women</arm_group_label>
  </intervention>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      urine samples collected
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women attending Centre de Salud Beatriz Velasco de Aleman for health services
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Eligible to consent for research

          -  Able to read Spanish well enough to read the test instructions

          -  Able to give informed consent

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Beverly Winikoff, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gynuity Health Projects</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hillary Bracken, PhD</last_name>
    <phone>4342490286</phone>
    <email>hbracken@gynuity.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Meighan Tarnagada, MPH</last_name>
    <phone>4044337731</phone>
    <email>mtarnagada@gynuity.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centro de Slaud Beatriz Velasco de Aleman</name>
      <address>
        <city>Mexico City</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Armando C Almazan Barerra, Dr</last_name>
      <email>patriciosanhueza@prodigy.net.mx</email>
    </contact>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 18, 2015</study_first_submitted>
  <study_first_submitted_qc>November 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2015</study_first_posted>
  <last_update_submitted>February 23, 2018</last_update_submitted>
  <last_update_submitted_qc>February 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Congo Red Dot Test</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

